NEW YORK, March 22, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) is pleased to announce that it has been listed on the Berlin Stock Exchange. The trading symbol on the Berlin exchange will be "XR2", and the German securities-code (Wertpapierkennnummer) will be "US00756F2011924770'.
David Lieberman, CEO of APPI, said, "We are very pleased to be approved for trading in Euros on the Berlin Stock Exchange as we believe this will facilitate investment in APPI by European investors."

About Advanced Plant Pharmaceuticals, Inc.

Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of plant-based dietary and health supplements. The Company has a patent pending process that utilizes whole plants to manufacture all natural dietary and health supplements. APPI uses this process to manufacture products, which the company distributes worldwide through various marketing and distribution contracts. Current products include Sinusol (homeopathic allergy and nasal spray) Lo-Chol(tm). Corporate website: http://www.advancedplantpharm.com

Forward Looking Statements

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.

-0-
CONTACT: LC Group
(404) 261-1196